News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
588,111 Results
Type
Article (40220)
Company Profile (164)
Press Release (547727)
Section
Business (166817)
Career Advice (1383)
Deals (29336)
Drug Delivery (82)
Drug Development (69811)
Employer Resources (122)
FDA (15212)
Job Trends (13310)
News (286717)
Policy (27074)
Tag
2024 BioCapital Digital (5)
2024 BioForest Digital (6)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (5)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (13)
2024 Biotech Beach Digital (6)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (2)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (3)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 Lone Star Bio Digital (3)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2556)
Academic (1)
Accelerated approval (3)
Adcomms (17)
Allergies (80)
Alliances (44364)
ALS (84)
Alzheimer's disease (1237)
Antibody-drug conjugate (ADC) (112)
Approvals (15240)
Artificial intelligence (244)
Autoimmune disease (18)
Automation (14)
Bankruptcy (237)
Best Places to Work (10808)
BIOSECURE Act (13)
Biosimilars (68)
Biotechnology (111)
Bladder cancer (63)
Brain cancer (23)
Breast cancer (252)
Cancer (1976)
Cardiovascular disease (154)
Career advice (1190)
Career pathing (28)
CAR-T (129)
Cell therapy (388)
Cervical cancer (20)
Clinical research (57321)
Collaboration (764)
Compensation (278)
Complete response letters (17)
COVID-19 (2333)
CRISPR (35)
C-suite (216)
Cystic fibrosis (88)
Data (1888)
Decentralized trials (2)
Denatured (23)
Depression (37)
Diabetes (237)
Diagnostics (5965)
Digital health (17)
Diversity (9)
Diversity, equity & inclusion (36)
Drug discovery (103)
Drug pricing (82)
Drug shortages (27)
Duchenne muscular dystrophy (76)
Earnings (61391)
Editorial (29)
Employer branding (12)
Employer resources (110)
Events (85445)
Executive appointments (653)
FDA (16338)
Featured Employer (38)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (697)
Gene editing (90)
Generative AI (22)
Gene therapy (259)
GLP-1 (620)
Government (3967)
Grass and pollen (4)
Guidances (45)
Healthcare (17753)
Huntington's disease (17)
IgA nephropathy (19)
Immunology and inflammation (85)
Indications (25)
Infectious disease (2454)
Inflammatory bowel disease (128)
Inflation Reduction Act (7)
Influenza (48)
Intellectual property (80)
Interviews (214)
IPO (13204)
IRA (32)
Job creations (2942)
Job search strategy (1037)
Kidney cancer (10)
Labor market (16)
Layoffs (333)
Leadership (16)
Legal (5522)
Liver cancer (73)
Lung cancer (303)
Lymphoma (118)
Machine learning (3)
Management (45)
Manufacturing (242)
MASH (61)
Medical device (13958)
Medtech (13963)
Mergers & acquisitions (16633)
Metabolic disorders (583)
Multiple sclerosis (69)
NASH (17)
Neurodegenerative disease (72)
Neuropsychiatric disorders (18)
Neuroscience (1694)
NextGen: Class of 2025 (6093)
Non-profit (4258)
Northern California (2106)
Now hiring (18)
Obesity (306)
Opinion (169)
Ovarian cancer (70)
Pain (82)
Pancreatic cancer (73)
Parkinson's disease (127)
Partnered (20)
Patents (178)
Patient recruitment (94)
Peanut (44)
People (51191)
Pharmaceutical (34)
Pharmacy benefit managers (17)
Phase I (17667)
Phase II (25208)
Phase III (19272)
Pipeline (1014)
Podcasts (45)
Policy (90)
Postmarket research (2208)
Preclinical (6711)
Press Release (59)
Prostate cancer (94)
Psychedelics (26)
Radiopharmaceuticals (246)
Rare diseases (321)
Real estate (4875)
Recruiting (45)
Regulatory (19445)
Reports (25)
Research institute (2349)
Resumes & cover letters (181)
Rett syndrome (4)
RNA editing (4)
RSV (35)
Schizophrenia (63)
Series A (125)
Series B (82)
Service/supplier (12)
Sickle cell disease (45)
Southern California (1843)
Special edition (4)
Spinal muscular atrophy (136)
Sponsored (29)
Startups (3287)
State (1)
Stomach cancer (15)
Supply chain (54)
Tariffs (7)
The Weekly (22)
United States (19231)
Vaccines (589)
Venture capitalists (27)
Webinars (11)
Weight loss (200)
Women's health (34)
Worklife (12)
Date
Today (100)
Last 7 days (672)
Last 30 days (2509)
Last 365 days (30674)
2025 (7618)
2024 (32159)
2023 (36445)
2022 (46982)
2021 (50768)
2020 (49610)
2019 (43322)
2018 (32804)
2017 (29133)
2016 (27839)
2015 (32491)
2014 (24686)
2013 (20293)
2012 (21788)
2011 (22213)
2010 (20171)
Location
Africa (625)
Alabama (46)
Alaska (7)
Arizona (161)
Arkansas (12)
Asia (35304)
Australia (5894)
California (4835)
Canada (1645)
China (459)
Colorado (223)
Connecticut (265)
Delaware (125)
Europe (82716)
Florida (744)
Georgia (187)
Idaho (54)
Illinois (483)
India (20)
Indiana (298)
Iowa (8)
Japan (140)
Kansas (98)
Kentucky (24)
Louisiana (9)
Maine (37)
Maryland (813)
Massachusetts (3660)
Michigan (203)
Minnesota (340)
Mississippi (2)
Missouri (76)
Montana (30)
Nebraska (21)
Nevada (50)
New Hampshire (67)
New Jersey (1450)
New Mexico (25)
New York (1455)
North Carolina (916)
North Dakota (8)
Northern California (2106)
Ohio (189)
Oklahoma (12)
Oregon (30)
Pennsylvania (1150)
Puerto Rico (9)
Rhode Island (25)
South America (909)
South Carolina (19)
South Dakota (1)
Southern California (1843)
Tennessee (91)
Texas (718)
Utah (148)
Virginia (138)
Washington D.C. (49)
Washington State (480)
West Virginia (3)
Wisconsin (58)
588,111 Results for "advanced medical solutions group plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Genflow Biosciences PLC Announces Advancements in SIRT6 Variant Patent Application
February 20, 2025
·
5 min read
Deals
BD to Acquire Edwards Lifesciences’ Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader
BD, a leading global medical technology company, and Edwards Lifesciences, announced a definitive agreement under which BD will acquire Edwards’ Critical Care product group, a global leader in advanced monitoring solutions, for $4.2 billion in cash, unlocking new value creation opportunities and enhancing BD’s portfolio of smart connected care solutions.
June 3, 2024
·
8 min read
Press Releases
Advanced Medical Balloons announces its new hygh-tec Odor Solution™ product, broadening its catheter portfolio
March 25, 2025
·
3 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces FDA Annual Report
April 3, 2025
·
3 min read
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
Press Releases
Viromed Medical AG: UMECO Group Acquires Exclusive Marketing Rights in Asia for Cold Plasma Medical Devices ViroCAP(R) and PulmoPlas(R)
April 2, 2025
·
4 min read
Press Releases
INITIO Medical Group Installs Western Canada’s First GE Omni Legend PET/CT System , Advancing Cancer Diagnosis and Treatment for BC Patients and Beyond
January 23, 2025
·
3 min read
Neuboron Medical Group Advances Cancer Treatment: Introducing Next-Generation Boron Neutron Capture Therapy
Neuboron Medical Group (Neuboron) is pleased to announce significant progress in the commercialization of its comprehensive Boron Neutron Capture Therapy (BNCT) solution, marking a new era in the treatment of refractory tumors.
April 10, 2024
·
3 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Recruitment of Second Patient for Clinical Trials
March 17, 2025
·
2 min read
Hemogenyx Pharmaceuticals PLC Announces Operations Update - June 17, 2024
Hemogenyx Pharmaceuticals plc, the clinical stage biopharmaceutical group developing treatments for cancers and viral diseases, is pleased to provide an update on its ongoing activities and progress.
June 17, 2024
·
4 min read
1 of 58,812
Next
